An Epidemiological Study On The Parasite Cutaneous Leishmaniasis In Iraq
DOI:
https://doi.org/10.61132/obat.v3i2.1087Keywords:
Cutaneous, Leishmaniasis, Epidemiology, IraqAbstract
Leishmaniasis is recognized as a significant health concern in Iraq. The disease begins with minor elevations (papules) and progresses into ulcers. Epidemiological investigations play a crucial role in managing and implementing effective preventive strategies for this disease. This study examines the epidemiology of cutaneous leishmaniasis in Iraq over the past 7 years. This descriptive-analytical cross-sectional inquiry analyzed data concerning patients with cutaneous leishmaniasis over the previous 7 years at the Iraq Health Center. Demographic and epidemiological data of the patients were collected from healthcare centers in Iraq through collaborative efforts with healthcare facilities. Using SPSS software, epidemiological records of the patients were extracted and subjected to statistical analysis employing the chi-square test. Out of 175 patients examined, 88 were male (53%), and 87 were female (47%). The majority of patients belonged to the age bracket of 9 months to 4 years, with the lowest number of cases in the age group of 40 to 49 years. Mainly, the manifestations of the disease were observed on the facial region and limbs. Furthermore, a statistically significant correlation was observed between age groups and the type of leishmaniasis (P > 0.05), as well as between gender and the type of leishmaniasis (P > 0.05). According to the conducted analysis, the prevalence of the disease in Iraq showed a declining trend from 2008 to 2014. This reduction in the disease incidence can be attributed to the improvement in health education status and the adherence to personal hygiene practices among the population
Downloads
References
Al-Jabi, S. W. (2019). Arab world’s growing contribution to global leishmaniasis research (1998–2017): a bibliometric study. BMC Public Health, 19, 1–12.
Al-Mekhlafi, H. M., Madkhali, A. M., Ghailan, K. Y., Abdulhaq, A. A., Ghzwani, A. H., Zain, K. A., Atroosh, W. M., Alshabi, A., Khadashi, H. A., & Darraj, M. A. (2021). Residual malaria in Jazan region, southwestern Saudi Arabia: the situation, challenges and climatic drivers of autochthonous malaria. Malaria Journal, 20, 1–14.
Al-Warid, H. S., Al-Saqur, I. M., Kadhem, A. J., Al-Tuwaijari, S. B., Al-Zadawi, K. M., & Gompper, M. E. (2019). Spatial and demographic aspects of kala-azar (visceral leishmaniasis) in Iraq during 2011-2013.
Alemu, A. Y., Derseh, L., Kaba, M., Gadisa, E., & Alemu, K. (2023). Treatment outcomes of cutaneous leishmaniasis due to Leishmania aethiopica: A systematic review and meta-analysis. Plos One, 18(11), e0293529.
Bailey, F., Mondragon-Shem, K., Hotez, P., Ruiz-Postigo, J. A., Al-Salem, W., Acosta-Serrano, A., & Molyneux, D. H. (2017). A new perspective on cutaneous leishmaniasis—Implications for global prevalence and burden of disease estimates. PLoS Neglected Tropical Diseases, 11(8), e0005739.
Baker, R. E., Mahmud, A. S., Miller, I. F., Rajeev, M., Rasambainarivo, F., Rice, B. L., Takahashi, S., Tatem, A. J., Wagner, C. E., & Wang, L.-F. (2022). Infectious disease in an era of global change. Nature Reviews Microbiology, 20(4), 193–205.
Bhunia, G. S., Shit, P. K., Bhunia, G. S., & Shit, P. K. (2020). Introduction of visceral Leishmaniasis (kala-azar). Spatial Mapping and Modelling for Kala-Azar Disease, 1–18.
Caminade, C., McIntyre, K. M., & Jones, A. E. (2019). Impact of recent and future climate change on vector‐borne diseases. Annals of the New York Academy of Sciences, 1436(1), 157–173.
Castro, M. D. M., Rode, J., Machado, P. R. L., Llanos-Cuentas, A., Hueb, M., Cota, G., Rojas, I. V., Orobio, Y., Oviedo Sarmiento, O., & Rojas, E. (2023). Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study. PLoS Neglected Tropical Diseases, 17(1), e0011029.
Cowman, A. F., Healer, J., Marapana, D., & Marsh, K. (2016). Malaria: biology and disease. Cell, 167(3), 610–624.
Das, B. P., & Deobhankar, K. (2022). Management of insect borne human diseases–a case study on novel bio-larvicide for mosquito borne diseases including dengue. Indian Journal of Entomology, 61–76.
de Vries, H. J. C., & Schallig, H. D. (2022). Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. American Journal of Clinical Dermatology, 23(6), 823–840.
Díaz, A. V, Walker, M., & Webster, J. P. (2023). Reaching the World Health Organization elimination targets for schistosomiasis: the importance of a One Health perspective. Philosophical Transactions of the Royal Society B, 378(1887), 20220274.
Flaih, M. H. (2022). Geographical Distribution of Cutaneous Leishmaniasis and Pathogenesis. Leishmaniasis: General Aspects of a Stigmatized Disease, 99.
Ghatee, M. A., Taylor, W. R., & Karamian, M. (2020). The geographical distribution of cutaneous leishmaniasis causative agents in Iran and its neighboring countries, a review. Frontiers in Public Health, 8, 11.
Khan, A. U., Jamshaid, H., ud Din, F., Zeb, A., & Khan, G. M. (2022). Designing, optimization and characterization of trifluralin transfersomal gel to passively target cutaneous leishmaniasis. Journal of Pharmaceutical Sciences, 111(6), 1798–1811.
Kraft, E., Cho, K., & Hunter, J. G. (2020). Skin Lesions and Pressure Ulcers. Principles and Practice of Geriatric Surgery, 743–782.
Kumar, A., Pandey, S. C., & Samant, M. (2020). A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis. Parasite Immunology, 42(10), e12727.
Lozano, Y. Y., Giraldo, S. E., Zapata, A. C., Escobar, J. E., & Sánchez, R. M. (2023). Medicinal plants with antileishmanial activity on parasites responsible for new-world cutaneous leishmaniasis. A systematic review 2018-2022. Journal of Pharmacy & Pharmacognosy Research, 11(6), 975–1001.
Madusanka, R. K., Silva, H., & Karunaweera, N. D. (2022). Treatment of cutaneous leishmaniasis and insights into species-specific responses: a narrative review. Infectious Diseases and Therapy, 11(2), 695–711.
Makanjuola, R. O., & Taylor-Robinson, A. W. (2020). Improving Accuracy of Malaria Diagnosis in Underserved Rural and Remote Endemic Areas of Sub‐Saharan Africa: A Call to Develop Multiplexing Rapid Diagnostic Tests. Scientifica, 2020(1), 3901409.
Malvolti, S., Malhame, M., Mantel, C. F., Le Rutte, E. A., & Kaye, P. M. (2021). Human leishmaniasis vaccines: Use cases, target population and potential global demand. PLoS Neglected Tropical Diseases, 15(9), e0009742.
Mannan, S. Bin, Elhadad, H., Loc, T. T. H., Sadik, M., Mohamed, M. Y. F., Nam, N. H., Thuong, N. D., Hoang-Trong, B.-L., Duc, N. T. M., & Hoang, A. N. (2021). Prevalence and associated factors of asymptomatic leishmaniasis: a systematic review and meta-analysis. Parasitology International, 81, 102229.
Maurício, I. L., Bruschi, F., & Gradoni, L. (2018). The Leishmaniases: Old Neglected Tropical Diseases. The Leishmaniases: Old Neglected Tropical Diseases. Cham: Springer International Publishing, 15–30.
Mboussou, F., Ndumbi, P., Ngom, R., Kassamali, Z., Ogundiran, O., Van Beek, J., Williams, G., Okot, C., Hamblion, E. L., & Impouma, B. (2019). Infectious disease outbreaks in the African region: overview of events reported to the World Health Organization in 2018. Epidemiology & Infection, 147, e299.
Moradi, M., Rassi, Y., Abai, M. R., Zahraei Ramazani, A., Mohebali, M., & Rafizadeh, S. (2018). Some epidemiological aspects of cutaneous leishmaniasis with emphasis on vectors and reservoirs of disease in the borderline of Iran and Iraq. Journal of Parasitic Diseases, 42, 243–251.
Organization, W. H. (2023). World malaria report 2023. World Health Organization.
Packard, R. M. (2021). The making of a tropical disease: a short history of malaria. JHU Press.
Peres, M. A., Macpherson, L. M. D., Weyant, R. J., Daly, B., Venturelli, R., Mathur, M. R., Listl, S., Celeste, R. K., Guarnizo-Herreño, C. C., & Kearns, C. (2019). Oral diseases: a global public health challenge. The Lancet, 394(10194), 249–260.
Raffetto, J. D., Ligi, D., Maniscalco, R., Khalil, R. A., & Mannello, F. (2020). Why venous leg ulcers have difficulty healing: overview on pathophysiology, clinical consequences, and treatment. Journal of Clinical Medicine, 10(1), 29.
Rafique, A., Sani, S. S., Sultana, S., Sultana, T., Ashraf, A., & Mahmood, M. S. (2023). Cutaneous Leishmaniasis. In Leishmania Parasites-Epidemiology, Immunopathology and Hosts. IntechOpen.
Rebouças-Silva, J., Tadini, M. C., Devequi-Nunes, D., Mansur, A. L., S Silveira-Mattos, P., I de Oliveira, C., R Formiga, F., Berretta, A. A., Marquele-Oliveira, F., & Borges, V. M. (2020). Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of Leishmania braziliensis Infection. International Journal of Nanomedicine, 8659–8672.
Ribeiro, S. P. (2023). Evolutionary Ecology of Lutzomyia longipalpis: from Human and Canid-Inhabited Caves to Primary Vector of Leishmania infantum in South America.
Rocha, R., Pereira, A., & Maia, C. (2022). Non-endemic Leishmaniases reported globally in humans between 2000 and 2021—a comprehensive review. Pathogens, 11(8), 921.
Santos, M. A. F. (2020). Cytokine Gene Expression And Cellular Immune Response In Dogs With Leishmaniosis Before And Under The Two First-Line Treatment Protocols: New Insights Into The Animal Disease. Universidade de Lisboa (Portugal).
Scarpini, S., Dondi, A., Totaro, C., Biagi, C., Melchionda, F., Zama, D., Pierantoni, L., Gennari, M., Campagna, C., & Prete, A. (2022). Visceral leishmaniasis: Epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics. Microorganisms, 10(10), 1887.
Sharifi, I., Khosravi, A., Aflatoonian, M. R., Salarkia, E., Bamorovat, M., Karamoozian, A., Moghadam, M. N., Sharifi, F., Afshar, A. A., & Afshari, S. A. K. (2023). Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan. Frontiers in Public Health, 11, 1091709.
Singh, O. P., Hasker, E., Boelaert, M., & Sundar, S. (2016). Elimination of visceral leishmaniasis on the Indian subcontinent. The Lancet Infectious Diseases, 16(12), e304–e309.
Steverding, D. (2017). The history of leishmaniasis. Parasites & Vectors, 10, 1–10.
Talisuna, A. O., Okiro, E. A., Yahaya, A. A., Stephen, M., Bonkoungou, B., Musa, E. O., Minkoulou, E. M., Okeibunor, J., Impouma, B., & Djingarey, H. M. (2020). Spatial and temporal distribution of infectious disease epidemics, disasters and other potential public health emergencies in the World Health Organisation Africa region, 2016–2018. Globalization and Health, 16, 1–12.
Tesh, R. B. (2019). Phlebotomus fevers. In The Arboviruses (pp. 15–28). CRC Press.
Thakur, L., Singh, K. K., Shanker, V., Negi, A., Jain, A., Matlashewski, G., & Jain, M. (2018). Atypical leishmaniasis: A global perspective with emphasis on the Indian subcontinent. PLoS Neglected Tropical Diseases, 12(9), e0006659.
Torres-Guerrero, E., Quintanilla-Cedillo, M. R., Ruiz-Esmenjaud, J., & Arenas, R. (2017). Leishmaniasis: a review. F1000Research, 6.
Turmusani, M. (2018). Disabled people and economic needs in the developing world: A political perspective from Jordan. Routledge.
Ullah, S., Jan, A. H., Wazir, S. M., & Ali, N. (2009). Prevalence of cutaneous leishmaniasis in lower Dir District (NWFP), Pakistan. Journal of Pakistan Association of Dermatologists, 19, 212–215.
Uzun, S., Uslular, C., YÜCEL, A., Acar, M. A., Özpoyraz, M., & Memişoğlu, H. R. (1999). Cutaneous leishmaniasis: evaluation of 3074 cases in the Cukurova region of Turkey. British Journal of Dermatology, 140(2), 347–350.
Wamai, R. G., Kahn, J., McGloin, J., & Ziaggi, G. (2020). Visceral leishmaniasis: a global overview. Journal of Global Health Science, 2(1).
Zheng, J., Zhang, N., Shen, G., Liang, F., Zhao, Y., He, X., Wang, Y., He, R., Chen, W., & Xue, H. (2023). Spatiotemporal and seasonal trends of class A and B notifiable infectious diseases in China: retrospective analysis. JMIR Public Health and Surveillance, 9(1), e42820.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
